HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute phase proteins and plasma lipoproteins during antimony treatment in infantile visceral leishmaniasis.

Abstract
The purpose of this study was to determine the effects of antimony treatment on the altered lipoprotein system of four young Tunisians with visceral Leishmaniasis and to further investigate possible relationships between acute phase proteins (C-reactive protein and apolipoprotein SAA)-known to be increased in this disease-and lipid or apolipoprotein (apo) parameters measured before and throughout the treatment. A marked improvement of all investigated parameters was already observed after the first cure: the lecithin-cholesterol acyltransferase activity was the only parameter remaining deficient even at the end of the second cure. Statistical analysis reveals a significant inverse relationship between changes in C-reactive protein and changes in the plasma ratio of esterified to total cholesterol (r = -0.78; p < 0.001) as well as in plasma apoA-I concentration (r = -0.64; p < 0.01). Because no such correlation could be observed with apoSAA, results of this study suggest that the major mechanism of lowering the plasma levels of apoA-I and the plasma-cholesteryl content could be closely related to the appearance of large amounts of C-reactive protein in plasma or more likely to the process inducing the hepatic synthesis of this acute phase protein.
AuthorsR Kallel, E D Bekaert, D Y Dubois, L G Alcindor, M Ayrault-Jarrier, A Mebazza
JournalClinical physiology and biochemistry (Clin Physiol Biochem) Vol. 10 Issue 1 Pg. 8-12 ( 1993) ISSN: 0252-1164 [Print] Germany
PMID8339522 (Publication Type: Journal Article)
Chemical References
  • Antiprotozoal Agents
  • Apolipoproteins
  • Organometallic Compounds
  • apolipoprotein SAA
  • Meglumine
  • Meglumine Antimoniate
  • C-Reactive Protein
  • Antimony
Topics
  • Antimony (therapeutic use)
  • Antiprotozoal Agents (therapeutic use)
  • Apolipoproteins (blood)
  • C-Reactive Protein (metabolism)
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Leishmaniasis, Visceral (blood, drug therapy)
  • Male
  • Meglumine (therapeutic use)
  • Meglumine Antimoniate
  • Organometallic Compounds (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: